Testaankoop wants Belgium to take action against campaigns surrounding slimming medication after a fine of millions for pharmaceutical companies in France

Two French pharmaceutical companies have been fined a total of almost 2 million euros for advertising slimming drugs. Testaankoop also asks that the Federal Agency for Medicines and Health Products (FAGG) in Belgium take action against similar campaigns by Novo Nordisk and Eli Lilly. According to the consumer organization, both companies also invest heavily in marketing around slimming medication in our country.

ttn-3